10058-F4 - CAS 403811-55-2
Catalog number: 403811-55-2
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C12H11NOS2
Molecular Weight:
249.35
COA:
Inquire
Targets:
c-Myc
Description:
10058-F4 is a c-Myc inhibitor that specificallly inhibits the c-Myc-Max interaction and prevents transactivation of c-Myc target gene expression.
Purity:
>98%
MSDS:
Inquire
InChIKey:
SVXDHPADAXBMFB-JXMROGBWSA-N
InChI:
InChI=1S/C12H11NOS2/c1-2-8-3-5-9(6-4-8)7-10-11(14)13-12(15)16-10/h3-7H,2H2,1H3,(H,13,14,15)/b10-7+
Canonical SMILES:
CCC1=CC=C(C=C1)C=C2C(=O)NC(=S)S2
1.A high-throughput screening assay for assessing the viability of Cryptococcus neoformans under nutrient starvation conditions.
Dehdashti SJ;Abbott J;Nguyen DT;McKew JC;Williamson PR;Zheng W Anal Bioanal Chem. 2013 Aug;405(21):6823-9. doi: 10.1007/s00216-013-7134-4. Epub 2013 Jun 30.
Cryptococcus neoformans causes an estimated 600,000 AIDS-related deaths annually that occur primarily in resource-limited countries. Fluconazole and amphotericin B are currently available for the treatment of cryptococcal-related infections. However, fluconazole has limited clinical efficacy and amphotericin B requires intravenous infusion and is associated with high renal toxicity. Therefore, there is an unmet need for a new orally administrable anti-cryptococcal drug. We have developed a high-throughput screening assay for the measurement of C. neoformans viability in 1,536-well plate format. The signal-to-basal ratio of the ATP content assay was 21.9 fold with a coefficient of variation and Z' factor of 7.1% and 0.76, respectively. A pilot screen of 1,280 known compounds against the wild-type C. neoformans (strain H99) led to the identification of four active compounds including niclosamide, malonoben, 6-bromoindirubin-3'-oxime, and 5-[(4-ethylphenyl)methylene]-2-thioxo-4-thiazolidinone. These compounds were further tested against nine clinical isolates of C. neoformans, and their fungicidal activities were confirmed. The results demonstrate that this miniaturized C. neoformans assay is advantageous for the high-throughput screening of large compound collections to identify lead compounds for new anti-cryptococcal drug development.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related c-Myc Products


CAS 413611-93-5 10074-G5

10074-G5
(CAS: 413611-93-5)

10074-G5, similarly to 10058-F4, is an inhibitor of c-Myc-Maxdimerization (IC50= 146 μM) that suppresses its transcriptional activity. 10074-G5 binds to and dis...

CAS 403811-55-2 10058-F4

10058-F4
(CAS: 403811-55-2)

10058-F4 is a c-Myc inhibitor that specificallly inhibits the c-Myc-Max interaction and prevents transactivation of c-Myc target gene expression.

CAS 944547-46-0 Mycro 3

Mycro 3
(CAS: 944547-46-0)

Mycro 3 is potent and selective inhibitor of Myc-Max dimerization.

KJ Pyr 9
(CAS: 581073-80-5)

KJ Pyr 9 is a cell-permeable inhibitor of c-Myc (Kd = 6.5 nM) that disrupts Myc-Max interaction.

Chemical Structure

CAS 403811-55-2 10058-F4

Quick Inquiry

Verification code

Featured Items